STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work

Summary

Novo Nordisk presented a new strategy to expand its obesity franchise and diversify its pipeline while addressing investor pressure. The company plans to pursue direct-to-consumer initiatives as part of its growth approach.